Free access to treatments, therapies and information
Trialwell has taken on the ambitious goal of connecting the science community and the general public, calling it a symbiotic relationship that needs to be supported in order to facilitate future research in a cost-effective way.
Obviously, the more people take part in clinical trials and studies through Trialwell, the better the chances to support the development of new treatments and preventative strategies to tackle health threats. So far, Trialwell has rallied 1,200 participants in the UK and Finland for its cause.
“We also want to do our part in closing the current data gap; to raise awareness and encourage men and women from all ethnic groups to participate in research. At the same time, we need to reduce wellbeing polarity,” she says, adding that free access to treatments, therapies and information lies at the heart of the Trialwell ideology.
Trialwell has been built to be prevention-focused from day one:
“Prevention is kinder, cheaper and more effective than cure,” Holland points out.
The more people take part in clinical trials and studies, the better the chances to support the development of new treatments and preventative strategies.